BML Investment Partners, L.P. 13D and 13G filings for Terns Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-08 5:24 pm Unchanged |
2023-02-08 | 13G | Terns Pharmaceuticals, Inc. TERN |
BML Investment Partners, L.P. | 0 0.000% |
0 (Unchanged) |
Filing |
| 2023-02-08 5:23 pm Sale |
2023-02-08 | 13G | Terns Pharmaceuticals, Inc. TERN |
BML Investment Partners, L.P. | 0 0.000% |
-1,764,274 (Position Closed) |
Filing |
| 2022-06-07 4:41 pm Purchase |
2022-06-01 | 13G | Terns Pharmaceuticals, Inc. TERN |
BML Investment Partners, L.P. | 1,764,274 7.000% |
1,764,274 (New Position) |
Filing |